El rol de la estrategia en el desempeño dentro de la industria farmacéutica: Una revisión de la literatura

Mariela Rópolo; Claudia Beatriz Peretto; Alejandro Ernesto Bricker

doi:10.24215/23143738e169

Authors

Mariela Rópolo Universidad Nacional de Córdoba, Argentina https://orcid.org/0009-0009-8944-1374
Claudia Beatriz Peretto Universidad Nacional de Córdoba, Argentina https://orcid.org/0000-0001-7691-6654
Alejandro Ernesto Bricker Universidad Nacional del Centro de la Provincia de Buenos Aires, Argentina https://orcid.org/0000-0002-6942-1351

DOI:

https://doi.org/10.24215/23143738e169

Keywords:

strategy, performance, pharmaceutical Industry

Abstract

This paper conducts an exploratory literature review to analyze the strategy–performance link in the pharmaceutical industry, based on the two predominant approaches in the literature: the theory of strategic groups and Porter’s generic strategies (1985/1998). While most studies agree that strategy has an effect on profitability, these studies present limitations and arrive at different conclusions. This essay reviews the literature and traces the evolution of research over the years, integrating different approaches and highlighting the main strategies within this industry and their impact on organizational performance. This research may be useful for those interested in an industry where innovation, price intervention, research specialization, and quality are fundamental characteristics that define its behavior.

Downloads

Download data is not yet available.

Author Biographies

Mariela Rópolo, Universidad Nacional de Córdoba, Argentina

Profesora adjunta e investigadora de la Facultad de Ciencias Económicas de la Universidad Nacional de Córdoba. Contadora Pública (UNC), Estudiante doctoral en Ciencias Económicas, orientación Ciencias Empresariales (UNC). Directora de Finanzas del Laboratorio de Hemoderivados (UNC). Especialidades: Decisiones de inversión y financiamiento, aplicación de herramientas y modelos financieros, confección de informes para la toma de decisiones estratégicas en el ámbito de las finanzas de empresa.
Claudia Beatriz Peretto, Universidad Nacional de Córdoba, Argentina

Profesora adjunta de grado y posgrado e investigadora en la Facultad de Ciencias Económicas (U.N.C.). Contadora Pública (U.N.C.), Magister en Estadística Aplicada (U.N.C.) y Doctora en Ciencias Económicas de la Facultad de Ciencias Económicas – U.N.C. Integrante del Centro de Investigaciones en Ciencias Económicas, Grupo vinculado Conicet – UNC. Especialidad: modelos cuantitativos para la toma de decisiones, modelos de evaluación de eficiencia aplicación de herramientas y modelos financieros.
Alejandro Ernesto Bricker, Universidad Nacional del Centro de la Provincia de Buenos Aires, Argentina

Profesor asociado e investigador de la Facultad de Ciencias Económicas de la Universidad Nacional del Centro de la Provincia de Buenos Aires (UNICEN). Licenciado en Administración (UNICEN), Master en Ingeniería de la Innovación (Università di Bologna) y Master en Administración de Negocios (UNICEN) y Doctor en Administración (UNICEN). Especialidades: Planificación estratégica, modelos de negocios, gestión de la innovación y emprendedorismo.

References

Allen, R. y Helms, M. (2006). Linking strategic practices and organizational performance to Porter's generic strategies. Business Process Management Journal, 12(4), 433-454. https://doi.org/10.1108/14637150610678069

Bain, J. S. (1956). Barriers to New Competition. Harvard University Press.

Ben-Jebara, M. y Modi, S. B. (2021). Product personalization and firm performance: An empirical analysis of the pharmaceutical industry. Journal of Operations Management, 67(1), 82-104. https://doi.org/10.1002/joom.1109

Bogner, W. C. (1991). Patterns of Intra-Industry Competition: A Dynamic Analysis of Theoretical Foundations of Strategic Groups. University of Illinois at Urbana-Champaign.

Castillo Apraiz, J. y Matey, J. (2020). Customizing competitive strategy to entry timing: Implications for firm performance in the pharmaceutical industry. Managerial and Decision Economics, 41(6), 976-985. https://doi.org/10.1002/mde.3152

Castillo Apraiz, J., Richter, N., Matey, J. y Gudergan, S. (2021). The role of competitive strategy in the performance impact of exploitation and exploration quality management practices. European Business Review, 33(1). https://doi.org/10.1108/EBR-09-2019-0182

Caves, R. E. y Porter, M. E. (1977). From Entry Barriers to Mobility Barriers: Conjectural Decisions and Contrived Deterrence to New Competition. The Quarterly Journal of Economics, 91(2), 241-261. https://doi.org/10.2307/1885416

Cool, K. O. y Schendel, D. (1987). Strategic Group Formation and Performance: The Case of the US Pharmaceutical Industry, 1963-1982. Management Science, 33(9), 1102-1124. https://doi.org/10.1287/mnsc.33.9.1102

Cross, L. (1999). Strategy drives marketing success. Graphic Arts Monthly, 71(2), 96-106.

Dadfar, H., Dahlgaard, J. J., Brege, S. y Alamirhoor, A. (2013). Linkage between organizational innovation capability, product platform development and performance. Total Quality Management & Business Excellence, 24(7-8), 819-834. https://doi.org/10.1080/14783363.2013.791102

Erden, Z., Von Krogh, G., Nytorp, C. y Hultberg, M. (2009). Strategic groups in the biopharmaceutical industry: implications for performance. Drug Discovery Today, 14(15 y 16), 726-730. https://doi.org/10.1016/j.drudis.2009.04.004

Hunt, M. S. (1972). Competition in the Major Home Appliance Industry,1960-1970 [Tesis de doctorado no publicada]. Harvard University.

Leask, G. y Parker, D. (2006). Strategic group theory: review, examination and application in the UK pharmaceutical industry. Journal of Management Development, 25(4), 386–408. https://doi.org/10.1108/02621710610655846

Leask, G. y Parker, D. (2007). Strategic Group, Competitive Group and Performance within the U.K. Pharmaceutical Industry: Improving our understanding of the Competitive Process. Strategic Management Journal, 28(7), 723-745. https://doi.org/10.1002/smj.603

Malburg, C. (2000). Competing on costs. Industry Week, 249(17), 31.

Martens, R. (1988). Strategic group formation and performance: the case of the pharmaceutical industry in five E.C. countries 1978-1985 [Tesis de doctorado no publicada]. Antwerp University.

Mason, E. S. (1939). Price and production policies of large-scale enterprises. American Economic Review, 29(1), 61-74.

Mohammadzadeh, M., Mohammad Aarabi, S. y Salamzadeh, J. (2013). Organizational performance, Marketing strategy, and Financial strategic alignment: an empirical study on Iranian pharmaceutical firms. DARU: Journal of Pharmaceutical Sciences, 21(1), 65. https://doi.org/10.1186/2008-2231-21-65

Mohammadzadeh, M., Bakhtiari, N., Safarey, R. y Ghari, T. (2019). Pharmaceutical industry in export marketing: a closer look at competitiveness. International Journal of Pharmaceutical and Healthcare Marketing, 13(3), 331-345. https://doi.org/10.1108/IJPHM-02-2018-0011

Newman, H. H. (1973). Strategic Groups and the structure-performance relationship: A study with respect to the Chemical Process Industries [Tesis de doctorado no publicada]. Harvard University.

Newman, H. H. (1978). Strategic groups and the structure-performance relationship. The Review of Economics and Statistics, 60(3), 417-427.

Piña Mavárez, E. E. y Suárez Serrano, E. (2009). Relación grupos estratégicos-desempeño empresarial: análisis empírico de la industria farmacéutica española. Revista Venezolana de Gerencia, 14(47), 412-428.

Porter, M. E. (1979). The Structure within Industries and Companies' Performance. The Review of Economics and Statistics, 61(2), 214-227. https://doi.org/10.2307/1924589

Porter, M. E. (1998). The Competitive Advantage: Creating and Sustaining Superior Performance. Free Press. (Trabajo original publicado en 1985).

Rodríguez Pérez, G. (2006). La relación entre rentabilidad y estrategias genéricas en el sector farmacéutico. Revista Europea de Dirección y Economía de la Empresa, 15(2), 29-44.

Sánchez Guerrero, M. y Arellano González, A. (2017). Utilización del modelo del diagnóstico CANVAS en el análisis de un caso de la industria farmacéutica en México. Revista Ciencias Administrativas, 9, 005. https://doi.org/10.24215/23143738e005